RC48 Combined with Toripalimab As Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients

Clinical trial NCT06341400 · RECRUITING

Trial details

NCT number: NCT06341400
Sponsor: Zhujiang Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Bladder Cancer Muscle-Invasive Bladder Carcinoma

Start date: 2024-06-19
Primary completion: 2026-05-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.